Search Results - "Barkdull S"

TP53 and KRAS co-mutations are associated with worse outcomes in mucinous ovarian carcinomas.

Authors: Zhang Y Barkdull S Kontoyiannis PD et al.

Source: Frontiers in oncology [Front Oncol] 2025 Aug 14; Vol. 15, pp. 1573801. Date of Electronic Publication: 2025 Aug 14 (Print Publication: 2025).

Publication Type: Journal Article

Journal Info: Publisher: Frontiers Research Foundation] Country of Publication: Switzerland NLM ID: 101568867 Publication Model: eCollection Cited Medium: Print ISSN: 2234-943X (Print) Linking ISSN: 2234943X NLM ISO Abbreviation: Front Oncol Subsets: PubMed not MEDLINE

Single cell analysis of developing Merkel cells reveals the emergence of non-coding RNA biotypes as a hallmark of terminal differentiation.

Authors: Miao L Collado L Barkdull S et al.

Source: Cell death and differentiation [Cell Death Differ] 2026 Feb 03. Date of Electronic Publication: 2026 Feb 03.

Publication Type: Journal Article

Journal Info: Publisher: Nature Publishing Group Country of Publication: England NLM ID: 9437445 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1476-5403 (Electronic) Linking ISSN: 13509047 NLM ISO Abbreviation: Cell Death Differ Subsets: MEDLINE

Ultra-rare TP53 and KRAS variants predict survival in ICI-treated solid tumours.

Authors: Clemente-Suárez VJ Olivares R Yáñez-Sepúlveda R et al.

Source: Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico [Clin Transl Oncol] 2026 Mar 20. Date of Electronic Publication: 2026 Mar 20.

Publication Type: Journal Article

Journal Info: Publisher: Country of Publication: Italy NLM ID: 101247119 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1699-3055 (Electronic) Linking ISSN: 1699048X NLM ISO Abbreviation: Clin Transl Oncol Subsets: MEDLINE

PD‐L1, RB1 and mismatch repair protein immunohistochemical expression in neuroendocrine carcinoma, small cell type, of the uterine cervix.

Authors: Morgan, Sarah Slodkowska, Elzbieta Parra‐Herran, Carlos et al.

Source: Histopathology. Jun2019, Vol. 74 Issue 7, p997-1004. 8p. 1 Color Photograph, 2 Charts.

Merkel Cell Carcinoma: Therapeutic Update and Emerging Therapies.

Authors: Villani, Alessia Fabbrocini, Gabriella Costa, Claudia et al.

Source: Dermatology & Therapy. Jun2019, Vol. 9 Issue 2, p209-222. 14p.

Characterizing DNA methylation signatures and their potential functional roles in Merkel cell carcinoma.

Authors: Gujar, Hemant Mehta, Arjun Li, Hong-Tao et al.

Source: Genome Medicine. 8/16/2021, Vol. 13 Issue 1, p1-17. 17p.

Diffuse lichen planus-like keratoses and clinical pseudo-progression associated with avelumab treatment for Merkel cell carcinoma, a case report.

Authors: Cardis, Michael A. Jiang, Hong Strauss, Julius et al.

Source: BMC Cancer. 6/4/2019, Vol. 19 Issue 1, pN.PAG-N.PAG. 1p. 1 Color Photograph, 1 Diagram.

Association of Merkel Cell Polyomavirus Status With p53, RB1, and PD-L1 Expression and Patient Prognosis in Merkel Cell Carcinomas: Clinical, Morphologic, and Immunohistochemical Evaluation of 17 Cases.

Authors: Öğüt B Bayram EK İnan MA et al.

Source: Applied immunohistochemistry & molecular morphology : AIMM [Appl Immunohistochem Mol Morphol] 2023 Jul 01; Vol. 31 (6), pp. 371-378. Date of Electronic Publication: 2023 May 01.

Publication Type: Journal Article

Journal Info: Publisher: Lippincott Williams & Wilkins Country of Publication: United States NLM ID: 100888796 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1533-4058 (Electronic) Linking ISSN: 15334058 NLM ISO Abbreviation: Appl Immunohistochem Mol Morphol Subsets: MEDLINE

Prognostic Role of Tumoral PD-L1 and IDO1 Expression, and Intratumoral CD8+ and FoxP3+ Lymphocyte Infiltrates in 132 Primary Cutaneous Merkel Cell Carcinomas.

Authors: Donizy, Piotr Wu, Cheng-Lin Kopczynski, Janusz et al.

Source: International Journal of Molecular Sciences. Jun2021, Vol. 22 Issue 11, p5489. 1p.

Multidisciplinary Treatment, Including Locoregional Chemotherapy, for Merkel-Polyomavirus-Positive Merkel Cell Carcinomas: Perspectives for Patients Exhibiting Oncogenic Alternative Δ exon 6–7 TrkAIII Splicing of Neurotrophin Receptor Tropomyosin-Related Kinase A

Authors: Guadagni, Stefano Farina, Antonietta Rosella Cappabianca, Lucia Annamaria et al.

Source: International Journal of Molecular Sciences. Nov2020, Vol. 21 Issue 21, p8222. 1p.

Recent developments on checkpoint inhibitors, CAR T cells, and beyond for T cell-based immunotherapeutic strategies against cancer.

Authors: Ali S Arshad M Summer M et al.

Source: Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners [J Oncol Pharm Pract] 2025 Oct; Vol. 31 (7), pp. 1115-1144. Date of Electronic Publication: 2025 Mar 28.

Publication Type: Journal Article; Review

Journal Info: Publisher: SAGE Publications Country of Publication: England NLM ID: 9511372 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1477-092X (Electronic) Linking ISSN: 10781552 NLM ISO Abbreviation: J Oncol Pharm Pract Subsets: MEDLINE

Clinical Relevance of Liquid Biopsy in Melanoma and Merkel Cell Carcinoma.

Authors: Boyer, Magali Cayrefourcq, Laure Dereure, Olivier et al.

Source: Cancers. Apr2020, Vol. 12 Issue 4, p960-960. 1p.

Book Reviews.

Authors: Worby, Gus Blewett, Neal Hill, Lisa et al.

Source: Australian Journal of Political Science. Nov2002, Vol. 37 Issue 3, p565-606. 42p.

PD-L1 blockade with avelumab: A new paradigm for treating Merkel cell carcinoma.

Authors: Barkdull S Brownell I

Source: Cancer biology & therapy [Cancer Biol Ther] 2017 Dec 02; Vol. 18 (12), pp. 937-939. Date of Electronic Publication: 2017 Nov 27.

Publication Type: Journal Article

Journal Info: Publisher: Taylor & Francis Country of Publication: United States NLM ID: 101137842 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1555-8576 (Electronic) Linking ISSN: 15384047 NLM ISO Abbreviation: Cancer Biol Ther Subsets: MEDLINE

Evaluation of the potential for QTc prolongation with avelumab.

Authors: Vugmeyster Y Güzel G Hennessy M et al.

Source: Cancer chemotherapy and pharmacology [Cancer Chemother Pharmacol] 2019 Nov; Vol. 84 (5), pp. 1017-1026. Date of Electronic Publication: 2019 Sep 03.

Publication Type: Journal Article; Meta-Analysis

Journal Info: Publisher: Springer Verlag Country of Publication: Germany NLM ID: 7806519 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1432-0843 (Electronic) Linking ISSN: 03445704 NLM ISO Abbreviation: Cancer Chemother Pharmacol Subsets: MEDLINE

Platelet Metabolism and Other Targeted Drugs; Potential Impact on Immunotherapy.

Authors: Kanikarla-Marie P Lam M Sorokin AV et al.

Source: Frontiers in oncology [Front Oncol] 2018 Apr 20; Vol. 8, pp. 107. Date of Electronic Publication: 2018 Apr 20 (Print Publication: 2018).

Publication Type: Journal Article; Review

Journal Info: Publisher: Frontiers Research Foundation] Country of Publication: Switzerland NLM ID: 101568867 Publication Model: eCollection Cited Medium: Print ISSN: 2234-943X (Print) Linking ISSN: 2234943X NLM ISO Abbreviation: Front Oncol Subsets: PubMed not MEDLINE